Biogen Inc. (ETR:IDP)
Germany
· Delayed Price · Currency is EUR 108.60
-0.15 (-0.14%)
Jun 25, 2025, 3:41 PM CET
Biogen Employees
Biogen had 7,605 employees as of December 31, 2024. The number of employees increased by 35 or 0.46% compared to the previous year.
Employees
7,605
Change (1Y)
35
Growth (1Y)
0.46%
Revenue / Employee
€1,194,232
Profits / Employee
€179,967
Market Cap
15.91B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Healthineers AG | 72,000 |
| Merck KGaA | 59,020 |
| Bayer Aktiengesellschaft | 91,864 |
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,730 |
| Fielmann Group AG | 24,363 |
Biogen News
- 2 days ago - Biogen: Investors Are Missing The Bigger Picture - Seeking Alpha
- 6 days ago - 21GRAMS Wins Its First Gold Lion for Branded Pharma Campaign at Cannes Lions International Festival of Creativity - Financial Post
- 6 days ago - 20 companies in the S&P 500 whose investors have gained the greatest rewards from stock buybacks - Market Watch
- 7 days ago - Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia - GlobeNewsWire
- 7 days ago - What Does the Market Think About Biogen? - Benzinga
- 12 days ago - Biogen, UCB Take A Leap In Lupus With Promising Phase 3 Results - Benzinga
- 13 days ago - Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity - GlobeNewsWire
- 14 days ago - Biogen Inc. (BIIB) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript) - Seeking Alpha